Maternal OXygen Immediately before birth: The MOXIE feasibility study

Not Applicable

• Conditions: eonatal complications; Neonatal complications; Reproductive Health and Childbirth - Complications of newborn

• Registration Number: ACTRN12623001037695
• Lead Sponsor: Douglas Blank

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-09-26
• Last Update Posted: 18 March 2024

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Female
• Target Recruitment: 40

Inclusion Criteria

Expecting women between 32 weeks and 0 days to 41 weeks and 6 days gestational age giving birth

Exclusion Criteria

History of severe maternal epistaxis
History of major nasal/sinus surgery or pathology
Concurrent maternal chronic obstructive pulmonary disease (COPD) exacerbation
Fetus with congenital abnormality that would alter the expected SpO2 targets in the minutes after birth; ie antenatal diagnosis of ductal dependant cardiac lesions, congenital diaphragmatic hernia, etc.
Monochorionic twins with evidence of twin-to-twin transfusion syndrome or multiples of more than 2.

Study & Design

• Study Type: Interventional
• Study Design: Not specified